首页 > 最新文献

Health Economics Review最新文献

英文 中文
Lorenz curves of urban and rural health care expenditure in Colombia: analysis of a cohort of 4.6 million patients. 哥伦比亚城乡医疗保健支出的Lorenz曲线:对460万患者队列的分析。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-09-02 DOI: 10.1186/s13561-025-00662-3
Oscar Espinosa, Giancarlo Buitrago, Valeria Bejarano, Ramon Castaño

In Colombia, health expenditure is highly concentrated, with a small portion of the population incurring most costs, particularly in rural areas. Men show greater inequality than women. The study suggests that current risk-adjustment models have opportunities for improvement, emphasizing the need for better health premium definitions and stronger health policies.

在哥伦比亚,保健支出高度集中,由一小部分人口承担大部分费用,特别是在农村地区。男性比女性表现出更大的不平等。该研究表明,目前的风险调整模型有改进的机会,强调需要有更好的健康保费定义和更强有力的卫生政策。
{"title":"Lorenz curves of urban and rural health care expenditure in Colombia: analysis of a cohort of 4.6 million patients.","authors":"Oscar Espinosa, Giancarlo Buitrago, Valeria Bejarano, Ramon Castaño","doi":"10.1186/s13561-025-00662-3","DOIUrl":"10.1186/s13561-025-00662-3","url":null,"abstract":"<p><p>In Colombia, health expenditure is highly concentrated, with a small portion of the population incurring most costs, particularly in rural areas. Men show greater inequality than women. The study suggests that current risk-adjustment models have opportunities for improvement, emphasizing the need for better health premium definitions and stronger health policies.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"74"},"PeriodicalIF":3.3,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic burden and cost drivers of generalized pustular psoriasis: a systematic review. 全身性脓疱性银屑病的经济负担和成本驱动因素:系统综述。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-09-02 DOI: 10.1186/s13561-025-00670-3
Xin Qian Seah, Mustapha Mohammed, Siew Chin Ong
{"title":"Economic burden and cost drivers of generalized pustular psoriasis: a systematic review.","authors":"Xin Qian Seah, Mustapha Mohammed, Siew Chin Ong","doi":"10.1186/s13561-025-00670-3","DOIUrl":"10.1186/s13561-025-00670-3","url":null,"abstract":"","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"73"},"PeriodicalIF":3.3,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12403385/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening for postpartum depression at well child visits: evaluating the impact of Michigan's statewide initiative. 筛查产后抑郁症在健康儿童访问:评估密歇根州的全州倡议的影响。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-26 DOI: 10.1186/s13561-025-00671-2
Janet Currie, Anna Malinovskaya

Objective: To examine a 2018 rule change allowing pediatric providers to bill the child's Medicaid ID for post-partum depression (PPD) screening of mothers conducted during well-child visits, and document its relationship with PPD treatment and infant hospitalizations.

Study setting and design: Screening rates during well-child visits are calculated at the zip code level and used in linear probability and Instrumental Variable (IV) models to examine increases in screening after the policy change and relate them to PPD treatment and infant hospitalizations.

Data sources and analytic sample: Individual-level Medicaid claims were used to compute PPD screening rates and measures of PPD treatment and infant hospitalization.

Principal findings: The policy was associated with increases in screening rates, although take up was uneven and overall screening rates remained low at 8.8%. There was little overall increase in treatment, although in zip codes in the top third of screening rates, higher screening was associated with 10.1% higher probability of maternal treatment. Zip codes with high fractions in poverty and/or minority had low screening rates, but screening was more likely to be associated with increases in treatment in these areas. There are no effects in the full sample of children, but among children above the poverty line, the observed increases in screening reduced the probability of infant hospitalization in the first six months by 7.7%.

Conclusions: The policy change had only limited success increasing screening, but increased screening could lead to more maternal PPD treatment and lower infant hospitalization rates if accompanied by expanded access to PPD treatment.

目的:研究2018年的一项规则变化,该规则允许儿科医生在儿童就诊期间对母亲进行产后抑郁症(PPD)筛查时收取儿童医疗补助ID的费用,并记录其与产后抑郁症治疗和婴儿住院的关系。研究设置和设计:健康儿童就诊期间的筛查率按邮政编码水平计算,并用于线性概率和工具变量(IV)模型,以检查政策变化后筛查率的增加,并将其与产后抑郁症治疗和婴儿住院治疗联系起来。数据来源和分析样本:使用个人水平的医疗补助申请来计算PPD筛查率和PPD治疗和婴儿住院治疗的措施。主要发现:该政策与筛查率的增加有关,尽管接受率不均衡,总体筛查率仍然很低,为8.8%。总体而言,治疗几乎没有增加,尽管在筛查率排名前三分之一的邮政编码地区,筛查率越高,孕产妇接受治疗的可能性就越高10.1%。贫困和/或少数民族比例高的邮政编码的筛查率较低,但筛查更有可能与这些地区的治疗增加有关。在整个儿童样本中没有效果,但在贫困线以上的儿童中,观察到的筛查增加使婴儿在头六个月内住院的可能性降低了7.7%。结论:增加筛查的政策改变仅取得有限的成功,但如果扩大PPD治疗的可及性,增加筛查可能导致更多的孕产妇PPD治疗和更低的婴儿住院率。
{"title":"Screening for postpartum depression at well child visits: evaluating the impact of Michigan's statewide initiative.","authors":"Janet Currie, Anna Malinovskaya","doi":"10.1186/s13561-025-00671-2","DOIUrl":"10.1186/s13561-025-00671-2","url":null,"abstract":"<p><strong>Objective: </strong>To examine a 2018 rule change allowing pediatric providers to bill the child's Medicaid ID for post-partum depression (PPD) screening of mothers conducted during well-child visits, and document its relationship with PPD treatment and infant hospitalizations.</p><p><strong>Study setting and design: </strong>Screening rates during well-child visits are calculated at the zip code level and used in linear probability and Instrumental Variable (IV) models to examine increases in screening after the policy change and relate them to PPD treatment and infant hospitalizations.</p><p><strong>Data sources and analytic sample: </strong>Individual-level Medicaid claims were used to compute PPD screening rates and measures of PPD treatment and infant hospitalization.</p><p><strong>Principal findings: </strong>The policy was associated with increases in screening rates, although take up was uneven and overall screening rates remained low at 8.8%. There was little overall increase in treatment, although in zip codes in the top third of screening rates, higher screening was associated with 10.1% higher probability of maternal treatment. Zip codes with high fractions in poverty and/or minority had low screening rates, but screening was more likely to be associated with increases in treatment in these areas. There are no effects in the full sample of children, but among children above the poverty line, the observed increases in screening reduced the probability of infant hospitalization in the first six months by 7.7%.</p><p><strong>Conclusions: </strong>The policy change had only limited success increasing screening, but increased screening could lead to more maternal PPD treatment and lower infant hospitalization rates if accompanied by expanded access to PPD treatment.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"72"},"PeriodicalIF":3.3,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12379358/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of the perceived financial threat of COVID-19 and implications for household economic stability: an application of the partial proportional odds model. COVID-19感知金融威胁的决定因素及其对家庭经济稳定的影响:部分比例赔率模型的应用
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-22 DOI: 10.1186/s13561-025-00637-4
Maru Zewdu Kassie, Seyifemickael Amare Yilema, Alebachew Taye Belay, Najmeh Nakhaei Rad, Ding-Geng Chen

Background: The COVID-19 pandemic has been one of the most significant global health crises in recent years. This study aimed to assess the determinants of perceived financial threat of COVID-19 and its implications on household's economic stability in Ethiopia.

Methods: A cross-sectional study was conducted on 3058 households from the third round of the COVID-19 high-frequency phone survey of households (HFPS-HH) data, executed by the Central Statistical Agency of Ethiopia in partnership with the World Bank. The data were extracted and managed using STATA version 17. A partial proportional odds model was applied to assess the significant predictors that affect the perceived financial threat of COVID-19.

Result: The analysis revealed that 79.9% of respondents (95% CI: 78.5-81.4%) experienced some level of financial threat from the COVID-19 pandemic, with the majority of them (61.7%; 95% CI: 60.0-63.4%) perceiving it as a substantial financial threat. Key factors of financial threat included Age [AOR = 1.280, P = 0.008]; COVID-19 illness worry for substantial threat (AOR = 0.546, p < 0.001), for moderate threat (AOR = 0.562, P = 0.005)]; Ability to buy medicine for substantial threat [AOR = 0.546, p < 0.001], for moderate threat [AOR = 0.562, p = 0.005]; employed [AOR = 1.310, p = 0.014]; engagement in additional income activities for substantial threat [AOR = 3.428, p < 0.001], and for moderate threat [AOR = 3.043, P = 0.018].

Conclusion: The findings revealed that a significant proportion of respondents perceived COVID-19 as a financial threat, which adversely affected their economic stability. Vulnerability to financial threat was notably higher among older individuals, the unemployed, those unable to afford essential medicine, and respondents who expressed heightened concern about illness. In contrast, engagement in additional income-generating activities served as a protective factor. These results underscore the need for policymakers to prioritize inclusive social protection systems, expand access to affordable healthcare, promote employment opportunities, and facilitate income diversification. Such interventions are critical to enhancing household economic resilience and enabling a rapid response to future public health and economic crises. Additionally, future research should consider longitudinal designs to track changes in perceptions over time and incorporate broader economic indicators.

背景:COVID-19大流行是近年来最严重的全球卫生危机之一。本研究旨在评估对COVID-19金融威胁的感知决定因素及其对埃塞俄比亚家庭经济稳定的影响。方法:对埃塞俄比亚中央统计局与世界银行合作开展的第三轮COVID-19家庭高频电话调查(HFPS-HH)数据中的3058个家庭进行横断面研究。使用STATA版本17提取和管理数据。应用部分比例赔率模型来评估影响COVID-19感知财务威胁的重要预测因素。结果:分析显示,79.9%的受访者(95% CI: 78.5-81.4%)经历了来自COVID-19大流行的某种程度的财务威胁,其中大多数人(61.7%;95% CI: 60.0-63.4%)将其视为重大的财务威胁。财务威胁的关键因素包括年龄[AOR = 1.280, P = 0.008];结论:研究结果显示,相当一部分受访者认为COVID-19是一种金融威胁,这对他们的经济稳定产生了不利影响。在老年人、失业者、无法负担基本药物的人和对疾病表示高度关注的受访者中,受经济威胁的脆弱性明显更高。相比之下,参加额外的创收活动是一种保护因素。这些结果突出表明,政策制定者需要优先考虑包容性社会保护制度,扩大可负担医疗服务的可及性,促进就业机会,并促进收入多样化。这些干预措施对于增强家庭经济抵御能力和迅速应对未来的公共卫生和经济危机至关重要。此外,未来的研究应考虑纵向设计,以跟踪随着时间的推移观念的变化,并纳入更广泛的经济指标。
{"title":"Determinants of the perceived financial threat of COVID-19 and implications for household economic stability: an application of the partial proportional odds model.","authors":"Maru Zewdu Kassie, Seyifemickael Amare Yilema, Alebachew Taye Belay, Najmeh Nakhaei Rad, Ding-Geng Chen","doi":"10.1186/s13561-025-00637-4","DOIUrl":"10.1186/s13561-025-00637-4","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic has been one of the most significant global health crises in recent years. This study aimed to assess the determinants of perceived financial threat of COVID-19 and its implications on household's economic stability in Ethiopia.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on 3058 households from the third round of the COVID-19 high-frequency phone survey of households (HFPS-HH) data, executed by the Central Statistical Agency of Ethiopia in partnership with the World Bank. The data were extracted and managed using STATA version 17. A partial proportional odds model was applied to assess the significant predictors that affect the perceived financial threat of COVID-19.</p><p><strong>Result: </strong>The analysis revealed that 79.9% of respondents (95% CI: 78.5-81.4%) experienced some level of financial threat from the COVID-19 pandemic, with the majority of them (61.7%; 95% CI: 60.0-63.4%) perceiving it as a substantial financial threat. Key factors of financial threat included Age [AOR = 1.280, P = 0.008]; COVID-19 illness worry for substantial threat (AOR = 0.546, p < 0.001), for moderate threat (AOR = 0.562, P = 0.005)]; Ability to buy medicine for substantial threat [AOR = 0.546, p < 0.001], for moderate threat [AOR = 0.562, p = 0.005]; employed [AOR = 1.310, p = 0.014]; engagement in additional income activities for substantial threat [AOR = 3.428, p < 0.001], and for moderate threat [AOR = 3.043, P = 0.018].</p><p><strong>Conclusion: </strong>The findings revealed that a significant proportion of respondents perceived COVID-19 as a financial threat, which adversely affected their economic stability. Vulnerability to financial threat was notably higher among older individuals, the unemployed, those unable to afford essential medicine, and respondents who expressed heightened concern about illness. In contrast, engagement in additional income-generating activities served as a protective factor. These results underscore the need for policymakers to prioritize inclusive social protection systems, expand access to affordable healthcare, promote employment opportunities, and facilitate income diversification. Such interventions are critical to enhancing household economic resilience and enabling a rapid response to future public health and economic crises. Additionally, future research should consider longitudinal designs to track changes in perceptions over time and incorporate broader economic indicators.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"71"},"PeriodicalIF":3.3,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372326/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144973870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of outpatient palliative care on healthcare costs in Germany - an analysis of cancer and non-cancer patients based on health insurance data. 门诊姑息治疗对德国医疗保健费用的影响——基于健康保险数据的癌症和非癌症患者分析。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-20 DOI: 10.1186/s13561-025-00604-z
Melissa Hemmerling, Sabrina Schütte, Sveja Eberhard, Katharina van Baal, Stephanie Stiel, Jona Theodor Stahmeyer
<p><strong>Background: </strong>Palliative care (PC) aims at improving the quality of life of patients suffering from life-threatening and life-limiting illnesses. International studies have found that PC is not only helpful for controlling symptoms and reducing hospital stays at the end of life, but also associated with reduced healthcare costs. However, evidence on the economic implications of outpatient PC in Germany is scarce. Accordingly, the current study aimed at assessing the impact of outpatient PC on end-of-life costs, and measuring differences between cancer and non-cancer patients who did and did not receive outpatient PC.</p><p><strong>Methods: </strong>The study involved a retrospective, cross-sectional analysis of statutory health insurance data for individuals who died in 2019 and were older than 18 years at the time of death (34,012 individuals). To explore the impact of outpatient PC on end-of-life costs, three groups were formed: (1) all individuals, (2) individuals with a cancer diagnosis and (3) individuals with no cancer diagnosis. The data were analysed descriptively and linear regression models were conducted.</p><p><strong>Results: </strong>The descriptive results showed in the group of all individuals, patients receiving outpatient PC had higher costs in all healthcare sectors compared to those who did not receive outpatient PC. Cancer patients receiving outpatient PC had higher total healthcare costs (outpatient PC: 34,822€; no outpatient PC: 26,343€; p < 0.001) but lower hospital costs (outpatient PC: 17,485€; no outpatient PC: 18,713€; p = 0,004). Non-cancer patients receiving outpatient PC had similar total healthcare costs (p = 0.174) but lower hospital costs (outpatient PC: 11,505€; no outpatient PC: 12,667€; p = 0.001). The regression models showed significantly higher total healthcare costs (p < 0.001), outpatient physician costs (p < 0.001) and pharmaceutical costs (p < 0.001) for patients receiving outpatient PC in all groups. Also across all groups, hospital costs were similar between patients who were and were not receiving outpatient PC (all patients: + 40€, p = 0.808; cancer patients: -580€, p = 0.072; non-cancer patients: + 301€, p = 0.166).</p><p><strong>Conclusions: </strong>Unlike the findings of international studies, the present study found that outpatient PC is not associated with lower end-of-life costs. The results for hospital costs were heterogeneous, but there was a trend towards lower costs for cancer patients receiving outpatient PC. Comparability with (inter)national studies remains difficult because financing systems and access to healthcare services are not internationally consistent. Many studies recommend the early integration of PC. Further analyses should investigate the connection between the time of initiating PC and end-of-life costs.</p><p><strong>Trial registration: </strong>The main study was registered in the German Clinical Trials Register (Registration N° DRKS00024785; date of
背景:姑息治疗(Palliative care, PC)旨在改善患有危及生命和限制生命疾病患者的生活质量。国际研究发现,PC不仅有助于控制症状和减少生命末期的住院时间,而且还与降低医疗费用有关。然而,关于门诊PC在德国的经济影响的证据是稀缺的。因此,目前的研究旨在评估门诊PC对临终成本的影响,并测量接受和未接受门诊PC的癌症和非癌症患者之间的差异。方法:该研究对2019年死亡且死亡时年龄大于18岁的个人(34,012人)的法定健康保险数据进行了回顾性横断面分析。为了探讨门诊PC对临终费用的影响,我们分成三组:(1)所有个体,(2)有癌症诊断的个体和(3)没有癌症诊断的个体。对数据进行描述性分析,建立线性回归模型。结果:描述性结果显示,在所有个体组中,接受门诊PC的患者在所有医疗保健部门的费用均高于未接受门诊PC的患者。接受门诊PC治疗的癌症患者总医疗费用较高(门诊PC: 34,822欧元;未接受门诊PC治疗:26,343欧元)。结论:与国际研究结果不同,本研究发现门诊PC治疗与较低的临终成本无关。住院费用的结果存在异质性,但接受门诊PC治疗的癌症患者有降低费用的趋势。与(国际)国家研究的可比性仍然很困难,因为筹资系统和获得保健服务的机会在国际上并不一致。许多研究建议尽早整合PC。进一步的分析应该调查PC启动时间和寿命终止成本之间的关系。试验注册:主要研究已在德国临床试验注册中心注册(注册号为DRKS00024785,注册日期为2021年5月6日)。
{"title":"Impact of outpatient palliative care on healthcare costs in Germany - an analysis of cancer and non-cancer patients based on health insurance data.","authors":"Melissa Hemmerling, Sabrina Schütte, Sveja Eberhard, Katharina van Baal, Stephanie Stiel, Jona Theodor Stahmeyer","doi":"10.1186/s13561-025-00604-z","DOIUrl":"10.1186/s13561-025-00604-z","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Palliative care (PC) aims at improving the quality of life of patients suffering from life-threatening and life-limiting illnesses. International studies have found that PC is not only helpful for controlling symptoms and reducing hospital stays at the end of life, but also associated with reduced healthcare costs. However, evidence on the economic implications of outpatient PC in Germany is scarce. Accordingly, the current study aimed at assessing the impact of outpatient PC on end-of-life costs, and measuring differences between cancer and non-cancer patients who did and did not receive outpatient PC.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The study involved a retrospective, cross-sectional analysis of statutory health insurance data for individuals who died in 2019 and were older than 18 years at the time of death (34,012 individuals). To explore the impact of outpatient PC on end-of-life costs, three groups were formed: (1) all individuals, (2) individuals with a cancer diagnosis and (3) individuals with no cancer diagnosis. The data were analysed descriptively and linear regression models were conducted.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The descriptive results showed in the group of all individuals, patients receiving outpatient PC had higher costs in all healthcare sectors compared to those who did not receive outpatient PC. Cancer patients receiving outpatient PC had higher total healthcare costs (outpatient PC: 34,822€; no outpatient PC: 26,343€; p &lt; 0.001) but lower hospital costs (outpatient PC: 17,485€; no outpatient PC: 18,713€; p = 0,004). Non-cancer patients receiving outpatient PC had similar total healthcare costs (p = 0.174) but lower hospital costs (outpatient PC: 11,505€; no outpatient PC: 12,667€; p = 0.001). The regression models showed significantly higher total healthcare costs (p &lt; 0.001), outpatient physician costs (p &lt; 0.001) and pharmaceutical costs (p &lt; 0.001) for patients receiving outpatient PC in all groups. Also across all groups, hospital costs were similar between patients who were and were not receiving outpatient PC (all patients: + 40€, p = 0.808; cancer patients: -580€, p = 0.072; non-cancer patients: + 301€, p = 0.166).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Unlike the findings of international studies, the present study found that outpatient PC is not associated with lower end-of-life costs. The results for hospital costs were heterogeneous, but there was a trend towards lower costs for cancer patients receiving outpatient PC. Comparability with (inter)national studies remains difficult because financing systems and access to healthcare services are not internationally consistent. Many studies recommend the early integration of PC. Further analyses should investigate the connection between the time of initiating PC and end-of-life costs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Trial registration: &lt;/strong&gt;The main study was registered in the German Clinical Trials Register (Registration N° DRKS00024785; date of ","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"70"},"PeriodicalIF":3.3,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12366161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144884103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand. 肾去神经治疗高血压:来自中国大陆、日本和泰国的成本-效果观察。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-13 DOI: 10.1186/s13561-025-00669-w
Dai Lian, Yue Suo, Ruoyan Gai, Ning Li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen

Background: Renal denervation (RDN) has been introduced as a novel non-pharmacological intervention for patients with hypertension that is poorly controlled by pharmacological means. Our study aims to evaluate the cost-effectiveness of the Netrod RDN treatment plus antihypertensives compared with antihypertensives alone for hypertension in Mainland China, Japan and Thailand.

Methods: A Markov decision-analytic model was developed to simulate the long-term clinical events, quality-adjusted life years (QALYs) and related costs among patients who underwent RDN regimen and antihypertensive regimen in line with Netrod-HTN trial, with yearly cycles over a 30-year horizon. This study adopted the perspectives of the healthcare systems. Cost and utility inputs were collected from published literature, price databases, expert consultations, and hospital information systems. Both costs and outcomes were discounted at a rate of 5%. Model validation, univariate and probabilistic sensitivity analyses, and scenario analyses were conducted to verify the robustness of the results.

Results: Compared with the antihypertensive regimen alone, the RDN regimen yielded a 30.61% reduction in cardiovascular, cerebral and renal events. Cost-effectiveness analysis showed the RDN regimen yielded the most favorable incremental cost-effectiveness ratio in Japan at $3,451 per QALY, followed by Thailand at $13,932 per QALY, and Mainland China at $19,049 per QALY. Sensitivity and scenario analyses confirmed the robustness of the findings.

Conclusions: Netrod RDN is a cost-effective intervention from the healthcare system perspective in Mainland China, Japan, and Thailand. However, its cost-effectiveness varies across countries, reflecting differences in socioeconomic contexts. In middle- and low-income countries, appropriate pricing strategies may play a key role in enhancing its affordability and cost-effectiveness.

背景:肾去神经支配(RDN)已被介绍为一种新的非药物干预高血压患者,药物手段控制不佳。本研究旨在评价Netrod RDN联合降压药治疗高血压与单独降压药治疗高血压在中国大陆、日本和泰国的成本-效果。方法:建立马尔可夫决策分析模型,模拟采用Netrod-HTN试验的RDN方案和降压方案患者的长期临床事件、质量调整生命年(QALYs)和相关费用,年周期超过30年。本研究采用医疗保健系统的观点。成本和效用输入收集自已发表的文献、价格数据库、专家咨询和医院信息系统。成本和结果均按5%折现。通过模型验证、单变量和概率敏感性分析以及情景分析来验证结果的稳健性。结果:与单独降压方案相比,RDN方案降低了30.61%的心血管、脑和肾事件。成本-效果分析显示,RDN方案在日本产生了最有利的增量成本-效果比,每个QALY为3,451美元,其次是泰国,每个QALY为13,932美元,中国大陆为每个QALY 19,049美元。敏感性和情景分析证实了研究结果的稳健性。结论:从中国大陆、日本和泰国的医疗系统角度来看,Netrod RDN是一种具有成本效益的干预措施。然而,其成本效益因国家而异,反映了社会经济背景的差异。在中低收入国家,适当的定价战略可在提高其可负担性和成本效益方面发挥关键作用。
{"title":"Renal denervation for hypertension: cross-country cost-effectiveness insights from mainland China, Japan, and Thailand.","authors":"Dai Lian, Yue Suo, Ruoyan Gai, Ning Li, Yunfeng Ren, Dunming Xiao, Jiaxin Zhao, Mingdong Zhang, Shimeng Liu, Yingyao Chen","doi":"10.1186/s13561-025-00669-w","DOIUrl":"10.1186/s13561-025-00669-w","url":null,"abstract":"<p><strong>Background: </strong>Renal denervation (RDN) has been introduced as a novel non-pharmacological intervention for patients with hypertension that is poorly controlled by pharmacological means. Our study aims to evaluate the cost-effectiveness of the Netrod RDN treatment plus antihypertensives compared with antihypertensives alone for hypertension in Mainland China, Japan and Thailand.</p><p><strong>Methods: </strong>A Markov decision-analytic model was developed to simulate the long-term clinical events, quality-adjusted life years (QALYs) and related costs among patients who underwent RDN regimen and antihypertensive regimen in line with Netrod-HTN trial, with yearly cycles over a 30-year horizon. This study adopted the perspectives of the healthcare systems. Cost and utility inputs were collected from published literature, price databases, expert consultations, and hospital information systems. Both costs and outcomes were discounted at a rate of 5%. Model validation, univariate and probabilistic sensitivity analyses, and scenario analyses were conducted to verify the robustness of the results.</p><p><strong>Results: </strong>Compared with the antihypertensive regimen alone, the RDN regimen yielded a 30.61% reduction in cardiovascular, cerebral and renal events. Cost-effectiveness analysis showed the RDN regimen yielded the most favorable incremental cost-effectiveness ratio in Japan at $3,451 per QALY, followed by Thailand at $13,932 per QALY, and Mainland China at $19,049 per QALY. Sensitivity and scenario analyses confirmed the robustness of the findings.</p><p><strong>Conclusions: </strong>Netrod RDN is a cost-effective intervention from the healthcare system perspective in Mainland China, Japan, and Thailand. However, its cost-effectiveness varies across countries, reflecting differences in socioeconomic contexts. In middle- and low-income countries, appropriate pricing strategies may play a key role in enhancing its affordability and cost-effectiveness.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"69"},"PeriodicalIF":3.3,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344921/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship. Côte科特迪瓦的治理和公共卫生支出:动态关系的审查。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-12 DOI: 10.1186/s13561-025-00627-6
Alliou Salihini Diarrassouba, Foungnigué Noé Coulibaly, Anzoumana Comoé

Background: The difficulties in mobilizing financial resources in developing countries combined with the low level of health of populations reveal the need to seek levers for optimal use of available resources. This paper aims at analyzing the dynamics of the relationship between governance and public health expenditure in Côte d'Ivoire as part of the "health for all" policy.

Methods: The estimates show, from a cointegration model based on the ARDL (self-regressive with staggered delays) approach and causality in the sense of that corruption influences and causes the increase in public health expenditure in the long term.

Results: The results includes poor health outcomes due to the diversion of resources on budgetary allocations. A 1% increase in the level of corruption generates 0.9% short-term and 0.5% long-term decrease in public health spending. Also, causality indicates a unidirectional link between the two variables ranging from corruption to the level of public health resources.

Conclusions: The authorities should therefore strengthen the institutional framework and the quality of central and internal governance of vertical health structures and programs in order to induce better use of resources likely to improve health outcomes.

背景:发展中国家在调动财政资源方面存在困难,加上人口的健康水平较低,这表明需要寻求最佳利用现有资源的手段。本文旨在分析Côte科特迪瓦作为“人人享有卫生保健”政策一部分的治理与公共卫生支出之间关系的动态。方法:通过基于ARDL(交错延迟自回归)方法的协整模型和因果关系的估计表明,腐败影响并导致了长期公共卫生支出的增加。结果:结果包括由于预算拨款的资源转移而导致的健康结果不佳。腐败程度每增加1%,公共卫生支出就会短期减少0.9%,长期减少0.5%。此外,因果关系表明,从腐败到公共卫生资源水平这两个变量之间存在单向联系。结论:因此,当局应加强机构框架和纵向卫生结构和方案的中央和内部治理的质量,以诱导更好地利用可能改善健康结果的资源。
{"title":"Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship.","authors":"Alliou Salihini Diarrassouba, Foungnigué Noé Coulibaly, Anzoumana Comoé","doi":"10.1186/s13561-025-00627-6","DOIUrl":"10.1186/s13561-025-00627-6","url":null,"abstract":"<p><strong>Background: </strong>The difficulties in mobilizing financial resources in developing countries combined with the low level of health of populations reveal the need to seek levers for optimal use of available resources. This paper aims at analyzing the dynamics of the relationship between governance and public health expenditure in Côte d'Ivoire as part of the \"health for all\" policy.</p><p><strong>Methods: </strong>The estimates show, from a cointegration model based on the ARDL (self-regressive with staggered delays) approach and causality in the sense of that corruption influences and causes the increase in public health expenditure in the long term.</p><p><strong>Results: </strong>The results includes poor health outcomes due to the diversion of resources on budgetary allocations. A 1% increase in the level of corruption generates 0.9% short-term and 0.5% long-term decrease in public health spending. Also, causality indicates a unidirectional link between the two variables ranging from corruption to the level of public health resources.</p><p><strong>Conclusions: </strong>The authorities should therefore strengthen the institutional framework and the quality of central and internal governance of vertical health structures and programs in order to induce better use of resources likely to improve health outcomes.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"68"},"PeriodicalIF":3.3,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12344930/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran. 伊朗新冠肺炎疫情期间隔离政策的成本效益分析
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-04 DOI: 10.1186/s13561-025-00626-7
Morteza Tahamipour Zarandi, Kimia Haghbandeh

Background: The outbreak of COVID-19 posed significant health and economic challenges worldwide, prompting governments to implement various containment measures, including quarantine policies. This study examines the cost-benefit analysis of Iran's quarantine policy during the pandemic, evaluating its economic impact, public health outcomes, and overall effectiveness. The research explores the direct and indirect costs of quarantine, including reduced economic activity, government expenditures, and social consequences, while assessing the benefits in terms of lives saved, healthcare system relief, and long-term economic stability. Findings suggest that while quarantine measures imposed substantial financial burdens, they played a crucial role in controlling the virus's spread and preventing a greater economic and human toll. The study highlights the necessity of balancing public health interventions with economic sustainability, offering insights for future pandemic response strategies.

Methods: This study has used the cost-benefit analysis method. In the financial evaluation, benefits such as the reduction of fuel costs, gratuitous payments, and the benefit of credits paid to employees have been compared to expenses such as the average cost of corona treatment in the hospital and at home for the population of employees who have contracted the disease. Also, in the economic evaluation, the benefits of reducing electricity costs and food for employees, the willingness of people to pay the government for protective measures, and reducing overtime payments to employees compared to costs such as food for hospitalized employees, paying subsidies to employees and reducing GDP Has been studied.

Results: Application of quarantine is optimal from the view of government employees (financial point of view) with a benefit-cost ratio of 1.98, and the government's point of view (economic point of view) is cost-effective with a benefit-cost ratio of 2.68.

Conclusions: These results indicate that applying quarantine for employees benefits both the people and the government. Thus, the results of this study can be a guide for policymakers in managing similar disasters or the spread of other strains of the Coronavirus in the future.

背景:2019冠状病毒病的爆发给全球带来了重大的卫生和经济挑战,促使各国政府实施各种遏制措施,包括隔离政策。本研究考察了疫情期间伊朗隔离政策的成本效益分析,评估了其经济影响、公共卫生结果和总体有效性。该研究探讨了隔离的直接和间接成本,包括减少经济活动、政府支出和社会后果,同时评估了拯救生命、医疗系统救济和长期经济稳定方面的好处。调查结果表明,虽然隔离措施造成了巨大的财政负担,但它们在控制病毒传播和防止更大的经济和人员伤亡方面发挥了关键作用。该研究强调了平衡公共卫生干预与经济可持续性的必要性,为未来的大流行应对战略提供了见解。方法:本研究采用成本效益分析法。在财务评价中,将减少燃料费用、无偿付款和支付给雇员的抵免福利等福利与感染该疾病的雇员在医院和家中接受冠状病毒治疗的平均费用等费用进行了比较。此外,在经济评价中,研究了降低员工的电费和食品成本的效益,人们向政府支付保护措施的意愿,以及减少员工的加班费,而不是住院员工的食品,向员工支付补贴和减少GDP等成本。结果:从政府雇员的角度(财务角度)来看,实施隔离是最优的,其效益成本比为1.98;从政府的角度(经济角度)来看,其效益成本比为2.68。结论:本研究结果表明,对员工实行隔离对人民和政府都有利。因此,这项研究的结果可以为政策制定者在未来管理类似灾难或其他冠状病毒株的传播提供指导。
{"title":"Cost-benefit analysis of the quarantine policy during the outbreak of the Covid-19 virus in Iran.","authors":"Morteza Tahamipour Zarandi, Kimia Haghbandeh","doi":"10.1186/s13561-025-00626-7","DOIUrl":"10.1186/s13561-025-00626-7","url":null,"abstract":"<p><strong>Background: </strong>The outbreak of COVID-19 posed significant health and economic challenges worldwide, prompting governments to implement various containment measures, including quarantine policies. This study examines the cost-benefit analysis of Iran's quarantine policy during the pandemic, evaluating its economic impact, public health outcomes, and overall effectiveness. The research explores the direct and indirect costs of quarantine, including reduced economic activity, government expenditures, and social consequences, while assessing the benefits in terms of lives saved, healthcare system relief, and long-term economic stability. Findings suggest that while quarantine measures imposed substantial financial burdens, they played a crucial role in controlling the virus's spread and preventing a greater economic and human toll. The study highlights the necessity of balancing public health interventions with economic sustainability, offering insights for future pandemic response strategies.</p><p><strong>Methods: </strong>This study has used the cost-benefit analysis method. In the financial evaluation, benefits such as the reduction of fuel costs, gratuitous payments, and the benefit of credits paid to employees have been compared to expenses such as the average cost of corona treatment in the hospital and at home for the population of employees who have contracted the disease. Also, in the economic evaluation, the benefits of reducing electricity costs and food for employees, the willingness of people to pay the government for protective measures, and reducing overtime payments to employees compared to costs such as food for hospitalized employees, paying subsidies to employees and reducing GDP Has been studied.</p><p><strong>Results: </strong>Application of quarantine is optimal from the view of government employees (financial point of view) with a benefit-cost ratio of 1.98, and the government's point of view (economic point of view) is cost-effective with a benefit-cost ratio of 2.68.</p><p><strong>Conclusions: </strong>These results indicate that applying quarantine for employees benefits both the people and the government. Thus, the results of this study can be a guide for policymakers in managing similar disasters or the spread of other strains of the Coronavirus in the future.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"67"},"PeriodicalIF":3.3,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144785620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is the construction of high-speed rail crowding out the market for medical care services at county? Quasi-experimental evidence from China. 高铁建设是否挤占了县域医疗服务市场?来自中国的准实验证据。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-08-02 DOI: 10.1186/s13561-025-00661-4
Liu Yang, Zhongliang Zhou, Yawei Huang, Sha Lai, Chi Shen

Background: Public transportation, including high-speed rail (HSR), exerts a significant influence on people's health and health-related behaviors in various ways around the world. Several studies have investigated the impact of HSR on patients' health-seeking behavior, however, many issues regarding the impact of HSR remain to be investigated in depth. We aim to explore whether the effect of HSR on patients' health-seeking behavior crowds out the market for medical services in county regions based on China's practice.

Methods: The opening of two important HSR lines connecting two megacities in western China, Xi'an to Chengdu (opened on December 6, 2017) and Yinchuan to Xi'an (opened on December 26, 2020), were considered as quasi-experimental intervention, and Event Study and Synthetic Difference-in-Differences (DID) research design were applied in this study. A monthly report database about county-level hospitals of the health statistical data collection from 2017 to 2018 and 2020 to 2021 was used.

Results: There is no significant change in the total number of visits (TOV) and the number of bed days occupied by discharged persons (BDODP) in county-level hospitals before and after the opening of two major HSR lines being observed. The estimates of TOV from synthetic DID were 319.38 (95% CI, -761.01, 1399.77) and -915.69 (95% CI, -5079.07, 3247.68) for the two HSR lines, respectively. The estimates of BDODP from synthetic DID were -581.34 (95% CI, -1555.27, 392.59) and -960.62 (95% CI, -3932.40, 2011,17) for the two HSR lines, respectively. The results from the event study DID estimates are in line with the synthetic DID.

Conclusions: Our findings suggest that the construction of HSR does not substantially modify the utilization of medical services at the county level. Moreover the effect of the construction of HSR on the flow of patients to large hospitals may be an incremental effect. These findings hold important implications for infrastructure policy, suggesting that improvements in transportation can coexist with and perhaps even bolster local healthcare services without compromising their usage.

背景:包括高速铁路(HSR)在内的公共交通在世界范围内以各种方式对人们的健康和健康相关行为产生重大影响。一些研究已经探讨了高铁对患者就医行为的影响,但关于高铁影响的许多问题仍有待深入研究。我们的目的是根据中国的实践,探讨高铁对患者就医行为的影响是否挤占了县域医疗服务市场。​采用2017 - 2018年和2020 - 2021年县级医院卫生统计数据收集月报数据库。结果:两条主要高铁线路开通前后,县级医院总就诊人次(TOV)和出院病人病床天数(BDODP)无显著变化。合成DID对两条高铁线路的TOV估计分别为319.38 (95% CI, -761.01, 1399.77)和-915.69 (95% CI, -5079.07, 3247.68)。合成DID对两条高铁线路的BDODP估计分别为-581.34 (95% CI, -1555.27, 392.59)和-960.62 (95% CI, -3932.40, 2011,17)。事件研究DID估计的结果与合成DID一致。结论:高铁建设并未对县域医疗服务利用产生实质性影响。此外,高铁建设对大医院患者流量的影响可能是一种增量效应。这些发现对基础设施政策具有重要意义,表明交通的改善可以与当地医疗服务共存,甚至可能在不影响其使用的情况下加强当地医疗服务。
{"title":"Is the construction of high-speed rail crowding out the market for medical care services at county? Quasi-experimental evidence from China.","authors":"Liu Yang, Zhongliang Zhou, Yawei Huang, Sha Lai, Chi Shen","doi":"10.1186/s13561-025-00661-4","DOIUrl":"10.1186/s13561-025-00661-4","url":null,"abstract":"<p><strong>Background: </strong>Public transportation, including high-speed rail (HSR), exerts a significant influence on people's health and health-related behaviors in various ways around the world. Several studies have investigated the impact of HSR on patients' health-seeking behavior, however, many issues regarding the impact of HSR remain to be investigated in depth. We aim to explore whether the effect of HSR on patients' health-seeking behavior crowds out the market for medical services in county regions based on China's practice.</p><p><strong>Methods: </strong>The opening of two important HSR lines connecting two megacities in western China, Xi'an to Chengdu (opened on December 6, 2017) and Yinchuan to Xi'an (opened on December 26, 2020), were considered as quasi-experimental intervention, and Event Study and Synthetic Difference-in-Differences (DID) research design were applied in this study. A monthly report database about county-level hospitals of the health statistical data collection from 2017 to 2018 and 2020 to 2021 was used.</p><p><strong>Results: </strong>There is no significant change in the total number of visits (TOV) and the number of bed days occupied by discharged persons (BDODP) in county-level hospitals before and after the opening of two major HSR lines being observed. The estimates of TOV from synthetic DID were 319.38 (95% CI, -761.01, 1399.77) and -915.69 (95% CI, -5079.07, 3247.68) for the two HSR lines, respectively. The estimates of BDODP from synthetic DID were -581.34 (95% CI, -1555.27, 392.59) and -960.62 (95% CI, -3932.40, 2011,17) for the two HSR lines, respectively. The results from the event study DID estimates are in line with the synthetic DID.</p><p><strong>Conclusions: </strong>Our findings suggest that the construction of HSR does not substantially modify the utilization of medical services at the county level. Moreover the effect of the construction of HSR on the flow of patients to large hospitals may be an incremental effect. These findings hold important implications for infrastructure policy, suggesting that improvements in transportation can coexist with and perhaps even bolster local healthcare services without compromising their usage.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"66"},"PeriodicalIF":3.3,"publicationDate":"2025-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12317508/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health shocks and households' vulnerability to poverty in Nigeria: a quasi-experimental analysis. 尼日利亚健康冲击和家庭对贫困的脆弱性:一项准实验分析。
IF 3.3 3区 经济学 Q1 ECONOMICS Pub Date : 2025-07-21 DOI: 10.1186/s13561-025-00660-5
Paul Eze, Chimere O Iheonu

Health shocks are a critical driver of poverty in low- and middle-income countries (LMICs). This study investigates the impact of health shocks on household poverty risk in Nigeria and evaluates the protective capacity of existing health insurance mechanisms, using data from the 2023/2024 General Household Survey (n = 4,779 households). We first estimated household vulnerability using Chaudhuri's (2003) Vulnerability as Expected Poverty framework, addressing heteroskedasticity in consumption estimation via feasible generalized least squares. We then modeled the probability of household vulnerability following health shocks using probit regression. Finally, we implemented propensity score matching to isolate the effect of health shocks on households' vulnerability. Our results indicate that 56.1% and 59.2% of Nigerian households are vulnerable to poverty, using the international ($2.15/day) and national ($2.48/day) poverty lines, respectively. Vulnerable households are more prevalent in northern regions, rural areas, larger households, and poorer households. We found evidence that, based on the international poverty line, health shocks significantly increased the probability of household vulnerability (ATT = 0.053, SE = 0.023) compared to matched households without health shocks, with a slightly higher impact (ATT = 0.054, SE = 0.023) if using the national poverty line. Household size, dependency ratio, household head's education and employment status, and residence were significant predictors of vulnerability. Despite their potential, health insurance, covering only 2.2% of households, did not offer adequate protection against health shocks. This study provides robust evidence that health shocks increase households' vulnerability to poverty and perpetuate existing poverty. Financial protection measures need to be considered in broader poverty reduction policies.

健康冲击是低收入和中等收入国家贫困的一个关键驱动因素。本研究利用2023/2024年综合住户调查(n = 4,779户)的数据,调查了健康冲击对尼日利亚家庭贫困风险的影响,并评估了现有健康保险机制的保护能力。我们首先使用Chaudhuri(2003)的脆弱性作为预期贫困框架来估计家庭脆弱性,通过可行广义最小二乘法解决消费估计中的异方差问题。然后,我们使用概率回归对健康冲击后家庭脆弱性的概率进行建模。最后,我们实施倾向得分匹配来隔离健康冲击对家庭脆弱性的影响。我们的研究结果表明,按照国际贫困线(2.15美元/天)和国家贫困线(2.48美元/天)计算,分别有56.1%和59.2%的尼日利亚家庭容易陷入贫困。弱势家庭在北部地区、农村地区、大家庭和较贫困家庭更为普遍。我们发现证据表明,与没有健康冲击的匹配家庭相比,基于国际贫困线的健康冲击显著增加了家庭脆弱性的概率(ATT = 0.053, SE = 0.023),如果使用国家贫困线,影响略高(ATT = 0.054, SE = 0.023)。家庭规模、抚养比、户主教育和就业状况以及居住地是脆弱性的显著预测因子。尽管健康保险具有潜力,但仅覆盖2.2%的家庭的健康保险并没有为健康冲击提供足够的保护。这项研究提供了强有力的证据,表明健康冲击增加了家庭对贫困的脆弱性,并使现有贫困永久化。需要在更广泛的减贫政策中考虑财政保护措施。
{"title":"Health shocks and households' vulnerability to poverty in Nigeria: a quasi-experimental analysis.","authors":"Paul Eze, Chimere O Iheonu","doi":"10.1186/s13561-025-00660-5","DOIUrl":"10.1186/s13561-025-00660-5","url":null,"abstract":"<p><p>Health shocks are a critical driver of poverty in low- and middle-income countries (LMICs). This study investigates the impact of health shocks on household poverty risk in Nigeria and evaluates the protective capacity of existing health insurance mechanisms, using data from the 2023/2024 General Household Survey (n = 4,779 households). We first estimated household vulnerability using Chaudhuri's (2003) Vulnerability as Expected Poverty framework, addressing heteroskedasticity in consumption estimation via feasible generalized least squares. We then modeled the probability of household vulnerability following health shocks using probit regression. Finally, we implemented propensity score matching to isolate the effect of health shocks on households' vulnerability. Our results indicate that 56.1% and 59.2% of Nigerian households are vulnerable to poverty, using the international ($2.15/day) and national ($2.48/day) poverty lines, respectively. Vulnerable households are more prevalent in northern regions, rural areas, larger households, and poorer households. We found evidence that, based on the international poverty line, health shocks significantly increased the probability of household vulnerability (ATT = 0.053, SE = 0.023) compared to matched households without health shocks, with a slightly higher impact (ATT = 0.054, SE = 0.023) if using the national poverty line. Household size, dependency ratio, household head's education and employment status, and residence were significant predictors of vulnerability. Despite their potential, health insurance, covering only 2.2% of households, did not offer adequate protection against health shocks. This study provides robust evidence that health shocks increase households' vulnerability to poverty and perpetuate existing poverty. Financial protection measures need to be considered in broader poverty reduction policies.</p>","PeriodicalId":46936,"journal":{"name":"Health Economics Review","volume":"15 1","pages":"65"},"PeriodicalIF":3.3,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281789/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144691921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health Economics Review
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1